×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Urolithin A for Neurodegeneration
therapeutic
3,258 words
KG: Urolithin A
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
Urolithin A for Neurodegeneration
💊
Therapeutic Info
Name
Urolithin A for Neurodegeneration
Summary
Page for Urolithin A for Neurodegeneration
Key Genes/Proteins
TFEB
,
RANKL
,
IL6
,
TNF
,
NLRP3
Related Diseases
osteoclastogenesis
,
Cognition
,
pyroptosis
Related Pathways
NF-kB pathway
,
Lysosomal function
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Multi-Modal Stress Response Harmonization
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Microbial Inflammasome Priming Prevention
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56
Smartphone-Detected Motor Variability Correction
Score: 0.56
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Circadian Clock-Autophagy Synchronization
Score: 0.55
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Retinal Vascular Microcirculation Rescue
Score: 0.54
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
Show 25 more
Related Experiments (30)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.46
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.46
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.46
Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.46
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.46
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.46
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.46
s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.46
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.46
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.46
s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.46
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.46
s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.46
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.46
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.46
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.46
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.46
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.46
Proposed experiment from debate on Senolytics targeting p16/
falsification · proposed · Score: 0.46
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.46
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.46
DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.46
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.46
Tau Co-Pathology in DLB Clinical Heterogeneity
clinical · proposed · Score: 0.46
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.46
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.46
Show 25 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 139 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 139 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 139 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 139 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 139 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 139 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 139 hypotheses
Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 37 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 139 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 139 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 139 hypotheses
Show 10 more
Knowledge Graph (12 edges)
Urolithin A
inhibits
RANKL
Urolithin A
inhibits
osteoclastogenesis
Urolithin A
inhibits
IL6
Urolithin A
inhibits
TNF
Urolithin A
inhibits
NF-kB pathway
Urolithin A
inhibits
NLRP3
Urolithin A
regulates
CTSZ
Urolithin A
inhibits
amyloid beta
Urolithin A
inhibits
tau
Urolithin A
inhibits
Amyloidogenesis